Investors in Technology

Got it! Innovacom has invested €1 billion in hundreds of technological startups within the digital economy. They operate through venture and seed funds, actively supporting early-stage companies that innovate in technologies, hardware, software products, services, and content aimed at both corporations and consumers. With a strong international presence and background, Innovacom provides not only capital but also valuable access to top partners and customers, enhancing the growth prospects of their portfolio companies.

At Crédit Mutuel Innovation, our focus is on investing in innovative companies in deeptech, digital, and life sciences sectors, leveraging our €4 billion in capital under management. We provide equity tickets ranging from €1 to €20 million to support entrepreneurs in realizing their growth potential. Beyond financial investment, we foster long-term relationships by connecting companies within our ecosystems, recognizing that creating a world leader often requires sustained support over more than 5 years. This approach ensures sustainable development and mutual success for our portfolio companies and partners.

At Quantonation, we identify and evaluate startups that align with our thesis through a rigorous process. We actively scout for companies leveraging genuine quantum effects and deep physics principles in fields such as cybersecurity, pharmaceutical design, finance, manufacturing, Artificial Intelligence, and Big Data. We engage with entrepreneurs who share our vision of harnessing quantum technologies to create disruptive applications that surpass traditional approaches.

InfraVia is a prominent independent private equity firm specializing in infrastructure and technology investments. We are dedicated to supporting entrepreneurs and companies throughout their growth journeys, facilitating business expansion and transformation into top-tier platforms. Since our inception in 2008, we have successfully raised approximately €10 billion in capital and have invested in over 50 companies across 13 European countries. Our mission is to drive sustainable growth and create value through strategic investments in sectors critical to infrastructure and technological advancement.

Kurma Partners is a leading European venture capital group specializing in healthcare, managing €470 million in assets. Our firm operates through two dedicated franchises: Kurma Biofund, which focuses on therapeutics (currently active with fund KBIII), and Kurma Diagnostics, which focuses on diagnostic and digital health (currently active with fund Kurma Dx2). We are committed to supporting innovation in healthcare by investing in promising companies that are poised to make significant advancements in therapeutic treatments and diagnostic technologies.

RockawayX is a blockchain-focused venture capital fund, with long-term focus on value creation. ​We invest globally into leading crypto funds, companies and protocols. After investment, we help by running the network of validators, auditing smart contracts, providing liquidity, engineering, hiring dev teams and building communities.

Integra Holdings is a unique venture fund that combines academic excellence, funding and R&D guidance together with a strong and proven business network — the most important elements necessary to bring academic innovation to the market. Focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in their respective fields, Integra takes a hands-on approach by providing our portfolio companies the strategic planning and business development necessary to bring their technology to the market. Founded by Yissum, the Hebrew University's technology transfer company, Integra capitalizes on the innovative applied research constantly flowing from the renowned Hebrew University of Jerusalem, Israel.

We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.

Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds. Finding and fueling tomorrow's advances in precision medicine.

Asterion Ventures is the first venture capital firm structured to support impact entrepreneurs from the seed phase and over the long term. We finance sustainable innovations likely to cause serial shifts and contribute to the profound transformation of the economic and social system. We back companies that create new market benchmarks, establish themselves as leaders in their sector, change the rules of the game, or lead entire industries toward better practices. At Asterion, we invest as lead investors, making 20 investments per year with ticket sizes ranging from €500,000 to €2M in pre-seed and seed rounds up to €5M. We provide patient capital over the long term, acting as a reference shareholder and maintaining our pro-rata during the series A and B rounds of our portfolio's investments throughout their value creation. Our community of seasoned investors gives their time to help our portfolio companies succeed.

Healthcare & Technology Venture Capital since 2001. Vi Partners is the longest-established Swiss Venture Capital firm. For more than 20 years, Vi Partners has been supporting innovative Technology and Healthcare companies, investing over CHF 330m in 66 startups. Vi Partners-managed funds are backed by Switzerland's most visible companies and institutions, including ETH Zurich, ABB, Buhler, Credit Suisse, Hilti, McKinsey, Nestlé, Schindler, Sulzer, Suva and ZKB as well as the European Investment Fund and many other institutional investors.

We focus exclusively on the earliest stages of company building, and we bring our portfolio companies the startup experience and network we have built as entrepreneurs, VCs, business angels, and investment bankers. We provide founders with the concrete, pragmatic, stimulating, and unreserved support they need during the first phase of their entrepreneurial journey.